SEC Form 4 · accession 0001289340-15-000057

Stereotaxis, Inc. · STXS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Jun 5, 2015

Accepted (ET)

Jun 9, 2015 · 5:10 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001289340

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Jun 5, 2015	S	55,476	$1.69	D	1,200,926	I	Sanderling Venture Partners VI Co-Investment Fund, L.P.
Common Stock^F2	Jun 8, 2015	S	38,120	$1.60	D	1,162,806	I	Sanderling Venture Partners VI Co-Investment Fund, L.P.
Common Stock^F3	Jun 9, 2015	S	13,280	$1.60	D	1,149,526	I	Sanderling Venture Partners VI Co-Investment Fund, L.P.
Common Stock	holding	—	—		—	46,810	D
Common Stock	holding	—	—		—	40,673	I	Sanderling Ventures Management VI
Common Stock	holding	—	—		—	6,358	I	Sanderling VI Limited Partnership
Common Stock	holding	—	—		—	5,335	I	Sanderling VI Beteiligungs GmbH & Co. KG
Common Stock	holding	—	—		—	1,500	I	Sanderling Mgmt. LLC 401K Pension Profit Sharing Plan
Common Stock	holding	—	—		—	53,275	I	Sanderling IV Biomedical Co-Investment Fund, L.P.
Common Stock	holding	—	—		—	11,097	I	Sanderling V Beteiligungs GmbH & Co. KG
Common Stock	holding	—	—		—	39,716	I	Sanderling V Biomedical Co-Investment Fund, L.P.
Common Stock	holding	—	—		—	11,956	I	Sanderling V Limited Partnership
Common Stock	holding	—	—		—	67,790	I	Sanderling Venture Partners V Co-Investment Fund, L.P.
Common Stock	holding	—	—		—	22,451	I	Sanderling Venture Partners IV Co-Investment Fund
Common Stock	holding	—	—		—	82	I	Sanderling Ventures Management V

No Table II lines on this filing.

F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $1.63 to $1.73, inclusive. The reporting person undertakes to provide to Stereotaxis, Inc., any security holder of Stereotaxis, Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $1.60 to $1.63, inclusive. The reporting person undertakes to provide to Stereotaxis, Inc., any security holder of Stereotaxis, Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $1.60 to $1.62, inclusive. The reporting person undertakes to provide to Stereotaxis, Inc., any security holder of Stereotaxis, Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.